BIONANO GENOMICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.17 USD | +5.41% |
|
+26.10% | -38.62% |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to Bionano Genomics Fir...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.11
USD
Average target price
6.667
USD
Spread / Average Target
+500.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.62% | 74.21M | |
| +12.87% | 227B | |
| +13.89% | 192B | |
| +18.07% | 136B | |
| +28.60% | 108B | |
| +1.67% | 64.07B | |
| +18.10% | 52.1B | |
| +7.04% | 51.87B | |
| +10.74% | 44.33B | |
| +5.70% | 36.75B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Transcript : Bionano Genomics, Inc., Q1 2020 Earnings Call, Jun 18, 2020
